Physician profile
Robert J Clower
NPI 1891394334
$359.69
in general payments reported to CMS, 2019-2025
9 companies · $36.82 in 2025
The $36.82 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.08 · 2024: $307 · 2025: $36.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.68 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $137.01 | 2024 | Stratafix |
| Novartis Pharmaceuticals Corporation | $41.41 | 2024 | |
| Intercept Pharmaceuticals, INC. | $33.66 | 2023-2024 | Ocaliva |
| Veloxis Pharmaceuticals, INC. | $31.98 | 2024 | Envarsus |
| Merck Sharp & Dohme LLC | $30.70 | 2024 | Prevymis |
| Pacira Pharmaceuticals Incorporated | $27.94 | 2024 | Exparel |
| Alexion Pharmaceuticals, INC. | $20.17 | 2024 | Ultomiris |
| Orphalan INC | $19.04 | 2025 | Cuvrior |
| Invivyd INC | $17.78 | 2025 | Pemgarda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Clower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.